Join the Ischemic Stroke - Prophylaxis group to help and get support from people like you.
Ischemic Stroke - Prophylaxis News (Page 9)
Related terms: Stroke, ischemic, Prophylaxis
Endometriosis Linked to Higher Heart Risks for Women
MONDAY, Sept 2, 2024 – Endometriosis can be a painful, debilitating condition for many women, but new research suggests even more serious consequences: higher odds for heart attacks or strokes....
Black Patients Less Likely to Receive Diagnostic Testing in Emergency Department
WEDNESDAY, Aug. 28, 2024 – Black patients are less likely than White patients with a nonspecific diagnosis of interest to receive related diagnostic testing in the emergency department, according to...
New 'Platelet Score' Could Gauge Your Odds for Stroke, Heart Attack
WEDNESDAY, Aug. 21, 2024 – An experimental genetic test can gauge a person’s risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than d...
Brilinta Approved in the US to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
6 November 2020 – AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic str...
Victoza (liraglutide) is Approved to Reduce the Risk of Three Major Adverse Cardiovascular Events in Type 2 Diabetes Patients
PLAINSBORO, N.J., Aug. 25, 2017 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza (liraglutide) to reduce the risk of major adverse cardiovascular...
FDA Approves Durlaza (aspirin) ER Capsules for Secondary Prevention of Stroke and Acute Cardiac Events
New Haven, CT, September 8th, 2015 – New Haven Pharmaceuticals, Inc. a privately held specialty pharmaceuticals company, today announced that the U.S. Food and Drug Administration (FDA) has approved D...
FDA Approves Zontivity to Reduce the Risk of Heart Attacks and Stroke
May 8, 2014 – The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore...
Further information
Related condition support groups
Related drug support groups
aspirin, Plavix, pravastatin, clopidogrel, Brilinta, Arthritis Pain, ticagrelor